1-4 of 4
Pawel Krzysztof Wlodarski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CDK12/13: A Promising New Therapeutic Target in ALL

Julia Dudkiewicz, Filip Garbicz, Pawel Krzysztof Wlodarski
Journal: Blood
Blood (2023) 142 (Supplement 1): 2266.
https://doi.org/10.1182/blood-2023-190038
Published: 2023
Journal Articles

Association of Telomere Length of Peripheral Blood Leukocyte with Hematological Response of Immunosuppressive Therapy in Children with Severe Aplastic Anemia

Katarzyna Pawelec, MD.PhD, Marek Janiak, Michal Matysiak, Prof., Malgorzata Salamonowicz, MD.PhD, Pawel Krzysztof Wlodarski, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4403.
https://doi.org/10.1182/blood.V120.21.4403.4403
Published: 2012
Journal Articles

Statins Increase Antileukemic Potency of Imatinib Through the Inhibition of MDR/ABCB1 and BCRP/ABCG2 Drug Transporters Activity

Eliza Glodkowska-Mrowka, MD, Piotr Mrowka, M.Sc., Magdalena Winiarska, PhD, Grzegorz Basak, MD, PhD, Joanna Niesiobedzka-Krezel, MD, Ilona Seferynska, MD, PhD, Pawel Krzysztof Wlodarski, MD, PhD, Marek Jakobisiak, MD, PhD, Tomasz Stoklosa, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2742.
https://doi.org/10.1182/blood.V118.21.2742.2742
Published: 2011
Journal Articles

Increased Telomere Length Is a Negative a Predicting Factor for IST in Children with Severe Aplastic Anemia?

Katarzyna Pawelec, MD.PhD, Marek Janiak, Michał Matysiak, MD.PhD, Pawel Krzysztof Wlodarski, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4381.
https://doi.org/10.1182/blood.V118.21.4381.4381
Published: 2011